期刊文献+

盐酸法舒地尔对蛛网膜下腔出血后血管痉挛的实验研究 被引量:6

Effect of fasudil hydrochloride on cerebral vasospasm following experimental subarachnoid hemorrhage
下载PDF
导出
摘要 目的通过建立大鼠蛛网膜下腔出血(SAH)模型,探讨盐酸法舒地尔对蛛网膜下腔出血后血管痉挛的缓解作用和神经保护作用,并与尼莫地平对比,观察疗效。方法通过枕大池二次注血法建立大鼠SAH模型,观察基底动脉和海马神经元形态变化,测量基底动脉管径和管壁厚度,计算海马CA1区神经元密度,检测基底动脉内皮型一氧化氮合成酶(eNOS)的表达。结果各组模型大鼠的基底动脉均出现血管痉挛,海马CA1区正常神经元数目明显减少,多数神经元发生变性,基底动脉的eNOS表达明显减弱。但注射法舒地尔组与其他模型组相比能较大程度的缓解以上变化,具有统计学差异(P<0.05),且优于尼莫地平。结论法舒地尔可以有效缓解SAH后的迟发性脑血管痉挛,具有神经保护作用,其缓解迟发性脑血管痉挛作用和神经保护作用与动脉壁产生的一氧化氮(NO)有关。 Objective To explore the mitigative effect on vasospasm and neural protective effect of fasudil hydrochloride on rat models of subarachnoid hemorrhage (SAH),with nimodipine as a control for the therapeutic effect.Methods SAH model was induced by double blood injection into cisterna magna of rats. The morphological changes of basilar artery and neurons of hippocampus were observed. The diameter and wall thickness of basilar artery were measured and the neuron density in the CA1 hippocampal field was calculated. The expression of endothelial nitric oxide synthase (eNOS) in basilar artery was detected.Results In all model groups,the vasospasm of basilar artery occurred,the amount of normal neurons in the CA1 hippocampal field was remarkedly decreased,degenerative changes occurred in the majority of neurons,and the expression of eNOS in basilar artery was decreased. But in fasudil hydrochloride treated group,all the changes were significantly mitigated. There was statistical significance compared with the other two groups (P0.05). The effect of fasudil hydrochloride was better than that of nimodipine.Conclusion Fasudil hydrochloride can attenuate the delayed cerebral vasospasm and protect the neurons after SAH,which is associated with the production of nitric oxide in the vessel wall of cerebral arteries.
出处 《中华神经外科疾病研究杂志》 CAS 2010年第5期427-431,共5页 Chinese Journal of Neurosurgical Disease Research
关键词 盐酸法舒地尔 迟发性血管痉挛 蛛网膜下腔出血 Fasudil hydrochloride Delayed cerebral vasospasm Subarachnoid hemorrhage
  • 相关文献

参考文献10

  • 1Kassell NF,Peerless SJ,Durward QJ,et al.Treatment of ischemic deficits from vasospasm with intracranial volume expansion and induced arterial hypertension[J].Neurosurgery,1982,11(3):337-343.
  • 2罗伟,许百男,韩德清.蛛网膜下腔出血后大鼠基底动脉肿瘤坏死因子-α的表达变化[J].中华神经外科疾病研究杂志,2009,8(6):500-504. 被引量:6
  • 3秦怀州,李立宏,王梁,宗建海,刘华峰,王举磊,高国栋.TRAIL参与氧合血红蛋白诱导的脑血管内皮细胞凋亡[J].中华神经外科疾病研究杂志,2009,8(2):140-143. 被引量:5
  • 4Ecker A,Riemenschneider PA.Arteriographic demonstration of spasm of the intracranial arteries,with special reference to saccular arterial aneurysms[J].J Neurosurg,1951,8(6):660-667.
  • 5Zheng Z,Yenari MA.Post-ischemic inflammation:molecular mechanisms and therapeutic implications[J].Neurol Res,2004,26(8):884-892.
  • 6Varsos VG,Liszczak TM,Han DH,et al.Delayed cerebral vasospasm is not reversible by aminophylline nifedipine or papaverine in a "two-hemorrhage" canine model[J].J Neurosurg,1983,58(1):11-17.
  • 7Batchelor TJ,Sadaba JR,Ishola A,et al.Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery[J].Br J Pharmacol,2001,132(1):302-308.
  • 8Wickman G,Lan C,Vollrath B.Functional roles of the rho/rho-kinase pathway and protein kinase C in the regulation of cerebrovascular constriction mediated by hemogobin:relevance to subarachnoid hemorrhage and vasospasm[J].Circ Res,2003,92(7):809-816.
  • 9Satoh S,Ikegaki I,Suzuki Y,et al.Neurprotective properties of a protein kinase inhibitor againse ischaemia-induced neuronal damage in rats and gerbils[J].Br J Pharmacol,1996,118(7):1592-1596.
  • 10Rikitake Y,Kim HH,Huang Z,et al.Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection[J].Stroke,2005,36(10):2251-2257.

二级参考文献16

  • 1Liu-Deryke X, Rhoney DH. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an review of pharmacologic management [ J]. Expert Opin Pharmacotherapy, 2006, 26 (2) : 182 - 203.
  • 2Ogihara K, Zubkov AY, Bernanke DH, et al. Oxyhemoglobin-induced apoptosis in cultured endothelial cells[ J ]. J Neurosurg, 1999, 91 (3) : 459 - 465.
  • 3Zhou C, Yamaguchi M, Kusaka G, et al. Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage [ J]. J Cereb Blood Flow Metab, 2004, 24(4) : 419 -431.
  • 4Humphreys RC, Halpern W. Trail receptors: targets for cancer therapy [J]. Adv Exp Med Biol, 2008, 615:127-158.
  • 5Kruyt FA. TRAIL and cancer therapy [ J ]. Cancer Lett, 2008, 263 (1): 14-25.
  • 6Mazumder S, Plesca D, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis [ J ]. Methods Mol Biol, 2008, 414:13 -21.
  • 7Corallini F, Rimondi E, Secchiero P. TRAIL and osteoprotegerin: a role in endothelial physiopathology ? [ J]. Front Biosci, 2008, 13 : 135 - 147.
  • 8Goehuico BR, Zhang J, Ma BY, et al. TRAIL expression in vascular smooth muscle [ J]. Am J Physiol Lung Cell Mol Physiol, 2000, 278 (5) : L1045 - 1050.
  • 9Pradilla G, Wang PP, Legnani FG, et al. Prevetion of vasopasm by anti-CD11/CD18 monoclonal antibody therapy following subarachnoid hemorrhage in rabbits [ J]. J Neurosurg, 2004, 101 (1) : 88 -92.
  • 10Dietrich HH, Dacey RG Jr. Molecular keys to the problems of cerebral vasospasm [J]. Neurosurgery, 2000, 46(3): 517-530.

共引文献9

同被引文献75

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部